nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Vandetanib—thyroid cancer	0.208	0.242	CbGbCtD
Apixaban—ABCG2—Sorafenib—thyroid cancer	0.125	0.146	CbGbCtD
Apixaban—ABCG2—Doxorubicin—thyroid cancer	0.0759	0.0883	CbGbCtD
Apixaban—CYP3A5—Sorafenib—thyroid cancer	0.0693	0.0807	CbGbCtD
Apixaban—CYP2C8—Sorafenib—thyroid cancer	0.0667	0.0776	CbGbCtD
Apixaban—CYP2C19—Sorafenib—thyroid cancer	0.0559	0.0651	CbGbCtD
Apixaban—CYP1A2—Sorafenib—thyroid cancer	0.0516	0.06	CbGbCtD
Apixaban—CYP2C9—Sorafenib—thyroid cancer	0.0465	0.0541	CbGbCtD
Apixaban—ABCB1—Sorafenib—thyroid cancer	0.0451	0.0525	CbGbCtD
Apixaban—CYP3A4—Vandetanib—thyroid cancer	0.0449	0.0522	CbGbCtD
Apixaban—ABCB1—Doxorubicin—thyroid cancer	0.0274	0.0319	CbGbCtD
Apixaban—CYP3A4—Sorafenib—thyroid cancer	0.027	0.0315	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—thyroid cancer	0.0164	0.0191	CbGbCtD
Apixaban—Haemoptysis—Vandetanib—thyroid cancer	0.00482	0.0348	CcSEcCtD
Apixaban—Cerebral haemorrhage—Sorafenib—thyroid cancer	0.00435	0.0314	CcSEcCtD
Apixaban—Haematoma—Sorafenib—thyroid cancer	0.00383	0.0276	CcSEcCtD
Apixaban—Blood bilirubin increased—Vandetanib—thyroid cancer	0.00377	0.0272	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00259	0.0187	CcSEcCtD
Apixaban—Blood bilirubin increased—Sorafenib—thyroid cancer	0.00254	0.0184	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00228	0.0165	CcSEcCtD
Apixaban—Haematochezia—Epirubicin—thyroid cancer	0.00221	0.0159	CcSEcCtD
Apixaban—Drug hypersensitivity—Epirubicin—thyroid cancer	0.00221	0.0159	CcSEcCtD
Apixaban—Drug hypersensitivity—Doxorubicin—thyroid cancer	0.00204	0.0148	CcSEcCtD
Apixaban—Haematochezia—Doxorubicin—thyroid cancer	0.00204	0.0148	CcSEcCtD
Apixaban—Haematuria—Vandetanib—thyroid cancer	0.0019	0.0137	CcSEcCtD
Apixaban—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00189	0.0136	CcSEcCtD
Apixaban—Epistaxis—Vandetanib—thyroid cancer	0.00188	0.0136	CcSEcCtD
Apixaban—Haemoglobin—Vandetanib—thyroid cancer	0.0018	0.013	CcSEcCtD
Apixaban—Haemorrhage—Vandetanib—thyroid cancer	0.00179	0.0129	CcSEcCtD
Apixaban—Urinary tract disorder—Vandetanib—thyroid cancer	0.00177	0.0128	CcSEcCtD
Apixaban—Urethral disorder—Vandetanib—thyroid cancer	0.00176	0.0127	CcSEcCtD
Apixaban—Eye disorder—Vandetanib—thyroid cancer	0.00167	0.0121	CcSEcCtD
Apixaban—Angiopathy—Vandetanib—thyroid cancer	0.00163	0.0117	CcSEcCtD
Apixaban—Mediastinal disorder—Vandetanib—thyroid cancer	0.00161	0.0117	CcSEcCtD
Apixaban—Breast disorder—Sorafenib—thyroid cancer	0.00158	0.0114	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00157	0.0114	CcSEcCtD
Apixaban—Gingival bleeding—Epirubicin—thyroid cancer	0.00157	0.0113	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00154	0.0111	CcSEcCtD
Apixaban—Transaminases increased—Epirubicin—thyroid cancer	0.00146	0.0106	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—thyroid cancer	0.00145	0.0105	CcSEcCtD
Apixaban—Loss of consciousness—Vandetanib—thyroid cancer	0.00137	0.0099	CcSEcCtD
Apixaban—Transaminases increased—Doxorubicin—thyroid cancer	0.00135	0.00977	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00132	0.00952	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—thyroid cancer	0.00128	0.00924	CcSEcCtD
Apixaban—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00127	0.00919	CcSEcCtD
Apixaban—Epistaxis—Sorafenib—thyroid cancer	0.00127	0.00917	CcSEcCtD
Apixaban—Nervous system disorder—Vandetanib—thyroid cancer	0.00125	0.00901	CcSEcCtD
Apixaban—Thrombocytopenia—Vandetanib—thyroid cancer	0.00125	0.009	CcSEcCtD
Apixaban—Skin disorder—Vandetanib—thyroid cancer	0.00124	0.00893	CcSEcCtD
Apixaban—Haemoglobin—Sorafenib—thyroid cancer	0.00121	0.00877	CcSEcCtD
Apixaban—Haemorrhage—Sorafenib—thyroid cancer	0.00121	0.00873	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—thyroid cancer	0.0012	0.00868	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.0012	0.00868	CcSEcCtD
Apixaban—Urinary tract disorder—Sorafenib—thyroid cancer	0.00119	0.00862	CcSEcCtD
Apixaban—Connective tissue disorder—Sorafenib—thyroid cancer	0.00119	0.00858	CcSEcCtD
Apixaban—Urethral disorder—Sorafenib—thyroid cancer	0.00118	0.00855	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—thyroid cancer	0.00118	0.00855	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—thyroid cancer	0.00111	0.00803	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00111	0.00803	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0011	0.00794	CcSEcCtD
Apixaban—Angiopathy—Sorafenib—thyroid cancer	0.0011	0.00792	CcSEcCtD
Apixaban—Immune system disorder—Sorafenib—thyroid cancer	0.00109	0.00788	CcSEcCtD
Apixaban—Mediastinal disorder—Sorafenib—thyroid cancer	0.00109	0.00787	CcSEcCtD
Apixaban—Petechiae—Epirubicin—thyroid cancer	0.00108	0.00781	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—thyroid cancer	0.001	0.00722	CcSEcCtD
Apixaban—Rectal haemorrhage—Epirubicin—thyroid cancer	0.000985	0.00711	CcSEcCtD
Apixaban—Anaemia—Sorafenib—thyroid cancer	0.000973	0.00702	CcSEcCtD
Apixaban—Syncope—Sorafenib—thyroid cancer	0.000944	0.00681	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00094	0.00679	CcSEcCtD
Apixaban—Loss of consciousness—Sorafenib—thyroid cancer	0.000925	0.00668	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.000911	0.00658	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00089	0.00642	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00087	0.00628	CcSEcCtD
Apixaban—Melaena—Epirubicin—thyroid cancer	0.000869	0.00627	CcSEcCtD
Apixaban—Anaphylactic shock—Sorafenib—thyroid cancer	0.000859	0.0062	CcSEcCtD
Apixaban—Shock—Sorafenib—thyroid cancer	0.000845	0.0061	CcSEcCtD
Apixaban—Nervous system disorder—Sorafenib—thyroid cancer	0.000842	0.00608	CcSEcCtD
Apixaban—Dizziness—Vandetanib—thyroid cancer	0.000842	0.00608	CcSEcCtD
Apixaban—Thrombocytopenia—Sorafenib—thyroid cancer	0.000841	0.00607	CcSEcCtD
Apixaban—Skin disorder—Sorafenib—thyroid cancer	0.000834	0.00602	CcSEcCtD
Apixaban—Ecchymosis—Epirubicin—thyroid cancer	0.000804	0.00581	CcSEcCtD
Apixaban—Melaena—Doxorubicin—thyroid cancer	0.000804	0.0058	CcSEcCtD
Apixaban—Rash—Vandetanib—thyroid cancer	0.000803	0.0058	CcSEcCtD
Apixaban—Dermatitis—Vandetanib—thyroid cancer	0.000802	0.00579	CcSEcCtD
Apixaban—Nausea—Vandetanib—thyroid cancer	0.000756	0.00546	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—thyroid cancer	0.000744	0.00537	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—thyroid cancer	0.000742	0.00536	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000742	0.00536	CcSEcCtD
Apixaban—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000741	0.00535	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000687	0.00496	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000687	0.00496	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000646	0.00466	CcSEcCtD
Apixaban—Hypersensitivity—Sorafenib—thyroid cancer	0.000633	0.00457	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000597	0.00431	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—thyroid cancer	0.000596	0.0043	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—thyroid cancer	0.000584	0.00421	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000581	0.0042	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00057	0.00411	CcSEcCtD
Apixaban—Dizziness—Sorafenib—thyroid cancer	0.000568	0.0041	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000552	0.00398	CcSEcCtD
Apixaban—Rash—Sorafenib—thyroid cancer	0.000541	0.00391	CcSEcCtD
Apixaban—Dermatitis—Sorafenib—thyroid cancer	0.000541	0.00391	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—thyroid cancer	0.00054	0.0039	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000538	0.00388	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000527	0.0038	CcSEcCtD
Apixaban—Nausea—Sorafenib—thyroid cancer	0.00051	0.00368	CcSEcCtD
Apixaban—Haematuria—Epirubicin—thyroid cancer	0.000474	0.00343	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000471	0.0034	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—thyroid cancer	0.000469	0.00339	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—thyroid cancer	0.000449	0.00324	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—thyroid cancer	0.000447	0.00323	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—thyroid cancer	0.000441	0.00319	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—thyroid cancer	0.000439	0.00317	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—thyroid cancer	0.000439	0.00317	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—thyroid cancer	0.000438	0.00316	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000435	0.00314	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—thyroid cancer	0.000434	0.00314	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—thyroid cancer	0.000417	0.00301	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—thyroid cancer	0.000415	0.003	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—thyroid cancer	0.000413	0.00298	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000408	0.00295	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000406	0.00293	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—thyroid cancer	0.000405	0.00293	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—thyroid cancer	0.000405	0.00293	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—thyroid cancer	0.000403	0.00291	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—thyroid cancer	0.000403	0.00291	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—thyroid cancer	0.000386	0.00279	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—thyroid cancer	0.000375	0.00271	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—thyroid cancer	0.000373	0.0027	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000373	0.00269	CcSEcCtD
Apixaban—Anaemia—Epirubicin—thyroid cancer	0.000359	0.00259	CcSEcCtD
Apixaban—Syncope—Epirubicin—thyroid cancer	0.000349	0.00252	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—thyroid cancer	0.000342	0.00247	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—thyroid cancer	0.000333	0.0024	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000329	0.00237	CcSEcCtD
Apixaban—Syncope—Doxorubicin—thyroid cancer	0.000323	0.00233	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—thyroid cancer	0.000317	0.00229	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—thyroid cancer	0.000316	0.00228	CcSEcCtD
Apixaban—Shock—Epirubicin—thyroid cancer	0.000312	0.00225	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—thyroid cancer	0.000311	0.00225	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—thyroid cancer	0.000311	0.00224	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—thyroid cancer	0.000308	0.00223	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000304	0.0022	CcSEcCtD
Apixaban—Hypotension—Epirubicin—thyroid cancer	0.000297	0.00214	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000294	0.00212	CcSEcCtD
Apixaban—Shock—Doxorubicin—thyroid cancer	0.000289	0.00209	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—thyroid cancer	0.000288	0.00208	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000288	0.00208	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—thyroid cancer	0.000285	0.00206	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—thyroid cancer	0.000274	0.00198	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000274	0.00198	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000254	0.00183	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—thyroid cancer	0.000234	0.00169	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—thyroid cancer	0.000216	0.00156	CcSEcCtD
Apixaban—Dizziness—Epirubicin—thyroid cancer	0.00021	0.00152	CcSEcCtD
Apixaban—Rash—Epirubicin—thyroid cancer	0.0002	0.00144	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—thyroid cancer	0.0002	0.00144	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—thyroid cancer	0.000194	0.0014	CcSEcCtD
Apixaban—Nausea—Epirubicin—thyroid cancer	0.000189	0.00136	CcSEcCtD
Apixaban—Rash—Doxorubicin—thyroid cancer	0.000185	0.00134	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—thyroid cancer	0.000185	0.00134	CcSEcCtD
Apixaban—Nausea—Doxorubicin—thyroid cancer	0.000174	0.00126	CcSEcCtD
Apixaban—CYP2J2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000171	0.0952	CbGpPWpGaD
Apixaban—CYP2J2—Metapathway biotransformation—CHST14—thyroid cancer	7.79e-05	0.0434	CbGpPWpGaD
Apixaban—CYP2J2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.34e-05	0.0297	CbGpPWpGaD
Apixaban—ABCG2—Iron uptake and transport—CP—thyroid cancer	4.46e-05	0.0248	CbGpPWpGaD
Apixaban—CYP2J2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.33e-05	0.0241	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	4.27e-05	0.0238	CbGpPWpGaD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—EPO—thyroid cancer	4.22e-05	0.0235	CbGpPWpGaD
Apixaban—ABCG2—Fluoropyrimidine Activity—SMUG1—thyroid cancer	3.86e-05	0.0215	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	3.81e-05	0.0212	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	3.47e-05	0.0194	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	3.16e-05	0.0176	CbGpPWpGaD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	3.15e-05	0.0175	CbGpPWpGaD
Apixaban—CYP2J2—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.07e-05	0.0171	CbGpPWpGaD
Apixaban—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	3e-05	0.0167	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	2.97e-05	0.0165	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	2.9e-05	0.0162	CbGpPWpGaD
Apixaban—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	2.54e-05	0.0142	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	2.48e-05	0.0138	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.44e-05	0.0136	CbGpPWpGaD
Apixaban—CYP2J2—Biological oxidations—RXRA—thyroid cancer	2.3e-05	0.0128	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	2.24e-05	0.0125	CbGpPWpGaD
Apixaban—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	1.97e-05	0.011	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	1.94e-05	0.0108	CbGpPWpGaD
Apixaban—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	1.92e-05	0.0107	CbGpPWpGaD
Apixaban—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	1.79e-05	0.01	CbGpPWpGaD
Apixaban—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	1.79e-05	0.00999	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	1.73e-05	0.00966	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	1.71e-05	0.00953	CbGpPWpGaD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	1.7e-05	0.00949	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—MINPP1—thyroid cancer	1.69e-05	0.00941	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	1.58e-05	0.00881	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	1.54e-05	0.00861	CbGpPWpGaD
Apixaban—F10—Hemostasis—PRKAR1A—thyroid cancer	1.54e-05	0.00858	CbGpPWpGaD
Apixaban—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.54e-05	0.00857	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	1.48e-05	0.00823	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—NDUFA13—thyroid cancer	1.44e-05	0.008	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	1.35e-05	0.00753	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CHST14—thyroid cancer	1.35e-05	0.00752	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	1.34e-05	0.00748	CbGpPWpGaD
Apixaban—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.33e-05	0.00742	CbGpPWpGaD
Apixaban—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.25e-05	0.00695	CbGpPWpGaD
Apixaban—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.19e-05	0.00663	CbGpPWpGaD
Apixaban—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	1.18e-05	0.00659	CbGpPWpGaD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.15e-05	0.00643	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—HPGD—thyroid cancer	1.09e-05	0.00606	CbGpPWpGaD
Apixaban—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.08e-05	0.00604	CbGpPWpGaD
Apixaban—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.08e-05	0.00602	CbGpPWpGaD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.08e-05	0.00601	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	1.04e-05	0.00581	CbGpPWpGaD
Apixaban—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	1.02e-05	0.0057	CbGpPWpGaD
Apixaban—F10—Hemostasis—IFNA2—thyroid cancer	1.02e-05	0.00569	CbGpPWpGaD
Apixaban—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.64e-06	0.00537	CbGpPWpGaD
Apixaban—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.27e-06	0.00516	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.22e-06	0.00513	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.83e-06	0.00492	CbGpPWpGaD
Apixaban—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.79e-06	0.0049	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	8.35e-06	0.00465	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	7.99e-06	0.00445	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.66e-06	0.00427	CbGpPWpGaD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.51e-06	0.00419	CbGpPWpGaD
Apixaban—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.15e-06	0.00398	CbGpPWpGaD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	7.11e-06	0.00396	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.84e-06	0.00381	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MINPP1—thyroid cancer	6.79e-06	0.00378	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—RXRA—thyroid cancer	6.62e-06	0.00369	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—TPR—thyroid cancer	6.25e-06	0.00348	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.23e-06	0.00347	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PRKAR1A—thyroid cancer	6.15e-06	0.00343	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.1e-06	0.0034	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.8e-06	0.00323	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NDUFA13—thyroid cancer	5.78e-06	0.00322	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—RXRA—thyroid cancer	5.74e-06	0.0032	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	5.69e-06	0.00317	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.57e-06	0.0031	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.44e-06	0.00303	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CHST14—thyroid cancer	5.43e-06	0.00303	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	5.37e-06	0.00299	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	5.37e-06	0.00299	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	5.33e-06	0.00297	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.28e-06	0.00294	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—RXRA—thyroid cancer	5.12e-06	0.00285	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.97e-06	0.00277	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.96e-06	0.00277	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MINPP1—thyroid cancer	4.87e-06	0.00271	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—SLC5A5—thyroid cancer	4.68e-06	0.00261	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—RXRA—thyroid cancer	4.67e-06	0.0026	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	4.6e-06	0.00256	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	4.43e-06	0.00247	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.38e-06	0.00244	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—HPGD—thyroid cancer	4.38e-06	0.00244	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.24e-06	0.00236	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MINPP1—thyroid cancer	4.22e-06	0.00235	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NDUFA13—thyroid cancer	4.14e-06	0.00231	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.02e-06	0.00224	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—RXRA—thyroid cancer	3.99e-06	0.00222	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—RXRA—thyroid cancer	3.93e-06	0.00219	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CHST14—thyroid cancer	3.89e-06	0.00217	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.82e-06	0.00213	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	3.81e-06	0.00212	CbGpPWpGaD
Apixaban—F10—Hemostasis—NRAS—thyroid cancer	3.81e-06	0.00212	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.76e-06	0.0021	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MINPP1—thyroid cancer	3.67e-06	0.00205	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.58e-06	0.002	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.43e-06	0.00191	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.38e-06	0.00188	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CHST14—thyroid cancer	3.37e-06	0.00188	CbGpPWpGaD
Apixaban—F10—Hemostasis—KRAS—thyroid cancer	3.28e-06	0.00182	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.24e-06	0.00181	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.2e-06	0.00178	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HPGD—thyroid cancer	3.14e-06	0.00175	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NDUFA13—thyroid cancer	3.12e-06	0.00174	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.08e-06	0.00172	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CHST14—thyroid cancer	3.01e-06	0.00168	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CHST14—thyroid cancer	2.94e-06	0.00164	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.93e-06	0.00163	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.92e-06	0.00163	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—thyroid cancer	2.91e-06	0.00162	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.9e-06	0.00162	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.9e-06	0.00162	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.86e-06	0.00159	CbGpPWpGaD
Apixaban—F10—Hemostasis—HRAS—thyroid cancer	2.78e-06	0.00155	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CHST14—thyroid cancer	2.74e-06	0.00153	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HPGD—thyroid cancer	2.72e-06	0.00151	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.69e-06	0.0015	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TPR—thyroid cancer	2.51e-06	0.0014	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.49e-06	0.00139	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PPARG—thyroid cancer	2.48e-06	0.00138	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PRKAR1A—thyroid cancer	2.47e-06	0.00138	CbGpPWpGaD
Apixaban—F10—Hemostasis—AKT1—thyroid cancer	2.46e-06	0.00137	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HPGD—thyroid cancer	2.42e-06	0.00135	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HPGD—thyroid cancer	2.37e-06	0.00132	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CHST14—thyroid cancer	2.34e-06	0.00131	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.28e-06	0.00127	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.26e-06	0.00126	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HPGD—thyroid cancer	2.21e-06	0.00123	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.2e-06	0.00123	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.17e-06	0.00121	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.06e-06	0.00115	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.99e-06	0.00111	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.97e-06	0.0011	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—thyroid cancer	1.95e-06	0.00109	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.92e-06	0.00107	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HPGD—thyroid cancer	1.89e-06	0.00105	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.88e-06	0.00105	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.83e-06	0.00102	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CHST14—thyroid cancer	1.81e-06	0.00101	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TPR—thyroid cancer	1.8e-06	0.001	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.79e-06	0.000999	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.77e-06	0.000987	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTEN—thyroid cancer	1.7e-06	0.000949	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—RXRA—thyroid cancer	1.58e-06	0.000881	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TPR—thyroid cancer	1.56e-06	0.000869	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.53e-06	0.000855	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.53e-06	0.000854	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.53e-06	0.000852	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HPGD—thyroid cancer	1.46e-06	0.000812	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TPR—thyroid cancer	1.39e-06	0.000776	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.39e-06	0.000775	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.37e-06	0.000763	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TPR—thyroid cancer	1.36e-06	0.000757	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.36e-06	0.000757	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.35e-06	0.000751	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.34e-06	0.000745	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TPR—thyroid cancer	1.27e-06	0.000707	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.25e-06	0.000696	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.24e-06	0.000692	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.17e-06	0.000651	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.15e-06	0.000639	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—RXRA—thyroid cancer	1.13e-06	0.000631	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.13e-06	0.000631	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.09e-06	0.00061	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TPR—thyroid cancer	1.09e-06	0.000605	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.07e-06	0.000595	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.04e-06	0.000581	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.02e-06	0.000567	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—thyroid cancer	9.98e-07	0.000556	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—RXRA—thyroid cancer	9.81e-07	0.000547	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—thyroid cancer	9.81e-07	0.000547	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.77e-07	0.000544	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.68e-07	0.000539	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.54e-07	0.000532	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC5A5—thyroid cancer	9.51e-07	0.00053	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.91e-07	0.000496	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—RXRA—thyroid cancer	8.76e-07	0.000488	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—RXRA—thyroid cancer	8.55e-07	0.000476	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.52e-07	0.000475	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TPR—thyroid cancer	8.37e-07	0.000467	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.24e-07	0.000459	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC5A5—thyroid cancer	8.12e-07	0.000453	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—RXRA—thyroid cancer	7.99e-07	0.000445	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—thyroid cancer	7.85e-07	0.000438	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.77e-07	0.000433	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.61e-07	0.000424	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—thyroid cancer	7.15e-07	0.000399	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—thyroid cancer	6.85e-07	0.000382	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—RXRA—thyroid cancer	6.82e-07	0.00038	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.64e-07	0.00037	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.27e-07	0.000349	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—thyroid cancer	6.2e-07	0.000345	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—thyroid cancer	5.63e-07	0.000313	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—thyroid cancer	5.53e-07	0.000308	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—thyroid cancer	5.4e-07	0.000301	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—RXRA—thyroid cancer	5.27e-07	0.000293	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—thyroid cancer	5.04e-07	0.000281	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—thyroid cancer	4.91e-07	0.000273	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.87e-07	0.000272	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.35e-07	0.000242	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—thyroid cancer	4.31e-07	0.00024	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—thyroid cancer	4.25e-07	0.000237	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—thyroid cancer	4.25e-07	0.000237	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.97e-07	0.000221	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—thyroid cancer	3.95e-07	0.00022	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—thyroid cancer	3.79e-07	0.000211	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—thyroid cancer	3.7e-07	0.000206	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—thyroid cancer	3.46e-07	0.000193	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.39e-07	0.000189	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—thyroid cancer	3.33e-07	0.000185	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—thyroid cancer	2.96e-07	0.000165	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—thyroid cancer	2.83e-07	0.000158	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.62e-07	0.000146	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—thyroid cancer	2.45e-07	0.000136	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—thyroid cancer	2.28e-07	0.000127	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—thyroid cancer	2.19e-07	0.000122	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—thyroid cancer	2.13e-07	0.000119	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—thyroid cancer	1.99e-07	0.000111	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—thyroid cancer	1.7e-07	9.49e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—thyroid cancer	1.31e-07	7.33e-05	CbGpPWpGaD
